A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine

Weill Cornell Breast Cancer Center, New York

North Shore Hematology Oncology Associates, East Setakuet

Huntington Medical Group, PC, Huntington Station

New York Oncology Hematology, P.C, Albany

SUNY Upstate Medical University, Syracuse

Frederick Memorial Hospital, Regional Cancer Therapy Center, Frederick

Fairfax Northern VA Hematology Oncology PC, Fairfax

Oncology and Hematology Associates, Salem

Raleigh Hematology Oncology Associates, Raleigh

Northwestern Carolina Oncology And Hematology, PA, Hudson

Charleston Hematology Oncology, Charleston

Peachtree Hematology And Oncology Consultants, Atlanta

Dr. Elizabeth Tan-Chiu, PA, Tamarac

Cancer Research Network, Plantation

Hematology-Oncology Associates, Port Saint Lucie

Birmingham Hematology and Oncology, Birmingham

Birmingham Hematology and Oncology, Birmingham

University of Tennessee Medical Center, Knoxville

Medical University of Ohio, Toledo

'Signal Point Hematology/Oncology, Inc., Middletown

Central Indiana Cancer Center, Indianapolis

Monroe Medical Center, Munster

Northern Indiana Cancer Research Consortium, South Bend

Park Nicollet Institute, Minneapolis

Montana Cancer Specialists, Missoula

University of Chicago, Chicago

Cancer Care and Hematology Specialist of Chicagoland, Niles

Decatur Memorial Hospital, Decatur

Missouri Cancer Associates, Columbia

University of Kansas Medical Center, Kansas City

Mercy Cancer Center, Hot Springs

Arkansas Cancer Research Center, Little Rock

Cancer Care Associates, Oklahoma City

Cancer Care Associates, Oklahoma City

Cancer Care Associates, Tulsa

North Texas Regional Cancer Center, Plano

Center For Oncology Research and Treatment, PA, Dallas

Texas Oncology PA, Dallas

Sammons Cancer Center-Dallas, Dallas

Tyler Cancer Center, Tyler

Texas Oncology, P.A. Bedford, Bedford

Texas Oncology PA, Houston

Baylor College of Medicine, Breast Cancer Clinic, Houston

Valley Oncology PA, Weslaco

Harrington Cancer Center, Amarillo

El Paso Cancer Treatment Center West, El Paso

El Paso Cancer Treatment Center, El Paso

Rocky Mountain Cancer Center, Littleton

Rocky Mountain Cancer Center-Midtown, Denver

Rocky Mountain Cancer Center-Rose, Denver

Utah Cancer Specialists, Salt Lake City

Comprehensive Cancer Centers of Nevada, Henderson

Wilshire Oncology Medical Group, Inc., La Verne

Northwest Cancer Specialist Rose Qtr, Portland

Kaiser Permanente, Central Interstate Clinic, Hematology Oncology, Portland

Northwest Cancer Specialist Hoyt, Portland

Willamette Valley Cancer Center, Eugene

Northwest Cancer Specialist, Vancouver

Yakima Valley Memorial Hospital, Yakima

Cancer Care Northwest, Spokane

Hamilton Health Sciences Juravinski Cancer Centre, Hamilton

NW Ontario Regional Cancer Centre, Thunder Bay

Toronto East General Hospital, Toronto

Centre Hospitaliere Universitaire de Montreal, Montreal

McGill University, Dept. of Oncology, Clinical Research Program, Montreal